GAMMA Investing’s Agios Pharmaceuticals AGIO Stock Holding History

GAMMA Investing’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$21.2K	Buy	638 +100	+19%	+$3.5K	﹤0.01%	2915
2026 Q2	$20K	Sell	538 -149	-22%	-$4.52K	﹤0.01%	2837
2026 Q1	$23.2K	Buy	687 +516	+302%	+$14.6K	﹤0.01%	2642
2025 Q4	$4.66K	Sell	171 -35	-17%	-$1.23K	﹤0.01%	3310
2025 Q3	$8.27K	Buy	206 +23	+13%	+$865	﹤0.01%	2970
2025 Q2	$6.09K	Sell	183 -96	-34%	-$2.91K	﹤0.01%	3046
2025 Q1	$8.18K	Buy	279 +192	+221%	+$6.37K	﹤0.01%	2850
2024 Q4	$2.86K	Sell	87 -103	-54%	-$4.84K	﹤0.01%	3109
2024 Q3	$8.44K	Buy	190 +118	+164%	+$5.36K	﹤0.01%	2529
2024 Q2	$3.1K	Buy	72 +24	+50%	+$866	﹤0.01%	2738
2024 Q1	$1.4K	Buy	48 +37	+336%	+$991	﹤0.01%	2861
2023 Q4	$249	Buy	+11	New	+$247	﹤0.01%	3106

Other funds holding AGIO

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

BWM

Bullock Wealth Management Bloomington, Indiana $241M AUM 23.31% 1-Year Est. Return

GAMMA Investing's AGIO Position: Q3 2026 in Review

GAMMA Investing increased its Agios Pharmaceuticals (AGIO) stake by 19% in Q3 2026, buying an estimated $3.5K and bringing the position to 638 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2915.

GAMMA Investing first reported a position in AGIO in Q4 2023 and has held it in 12 quarters since. The position peaked at $23.2K in Q1 2026. 4 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

GAMMA Investing held 638 shares of Agios Pharmaceuticals worth $21.2K as of Q3 2026.
GAMMA Investing bought 100 Agios Pharmaceuticals shares in Q3 2026, an estimated $3.5K.
Agios Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2915 holding.
GAMMA Investing first reported a position in Agios Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
GAMMA Investing's Agios Pharmaceuticals position peaked at $23.2K in Q1 2026.
4 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.